Citation Impact
Citing Papers
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
2015
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
2016
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
2021
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
2017
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
2015
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
2017
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
2018
Adverse Health Effects of Marijuana Use
2014 Standout
Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca
2011
Potential Therapeutic Effects of Psilocybin
2017 Standout
Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study
2012
Psychiatry & the psychedelic drugs. Past, present & future
2017
When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders
2011 StandoutNobel
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
2019 Standout
Classical hallucinogens and neuroimaging: A systematic review of human studies
2016
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
2013
Psychedelics
2016 Standout
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
2014
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
2017
Clinical applications of hallucinogens: A review.
2016
Artificial Intelligence for Mental Health Care: Clinical Applications, Barriers, Facilitators, and Artificial Wisdom
2021
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The Pharmacology of Lysergic Acid Diethylamide: A Review
2008
Assessment of addiction severity among ritual users of ayahuasca
2010
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
The neural basis of psychedelic action
2022 Standout
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Tripping on nothing: placebo psychedelics and contextual factors
2020 Standout
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
2017
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion
2011
Sleep Disturbances in Patients with Schizophrenia
2008
Ayahuasca: Pharmacology, neuroscience and therapeutic potential
2016
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
2015
Classical psychedelics for the treatment of depression and anxiety: A systematic review
2019
Taking Psychedelics Seriously
2018 Standout
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
2018
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
2017 Standout
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
2015
Pivotal mental states
2020
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
2018
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
2020
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Comparison of topical silver nitrate and flunisolide treatment in patients with idiopathic non-allergic rhinitis.
1996
American Trip
2020 Standout
Models of psychedelic drug action: modulation of cortical-subcortical circuits
2021
Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations
2017
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans
2015
Works of Eva Grasa being referenced
Pharmacology of ayahuasca administered in two repeated doses
2011
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
2006
Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers
2007
Mobile Phone and Wearable Sensor-Based mHealth Approaches for Psychiatric Disorders and Symptoms: Systematic Review
2018
Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
2007
Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: An in vivo SPECT study
2011